Clinical Penetrance of the Transthyretin V122I Variant in Older Black Patients With Heart Failure: The SCAN‐MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study

BACKGROUND: Transthyretin amyloid cardiomyopathy (ATTR‐CM) is an underdiagnosed cause of heart failure (HF) among patients ≥60 years of age. Although the V122I (valine to isoleucine substitution at position 122 of the transthyretin protein) variant associated with hereditary ATTR‐CM is present in 3....

Descripción completa

Detalles Bibliográficos
Autores principales: Madhani, Avni, Sabogal, Natalia, Massillon, Daniel, Paul, Ludwine D., Rodriguez, Carlos, Fine, Denise, Helmke, Stephen, Winburn, Morgan, Kurian, Damian, Raiszadeh, Farbod, Teruya, Sergio, Cohn, Elizabeth, Einstein, Andrew J., Miller, Edward J., Connors, Lawreen H., Maurer, Mathew S., Ruberg, Frederick L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492994/
https://www.ncbi.nlm.nih.gov/pubmed/37486082
http://dx.doi.org/10.1161/JAHA.122.028973

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492994/
https://www.ncbi.nlm.nih.gov/pubmed/37486082
http://dx.doi.org/10.1161/JAHA.122.028973

Ejemplares similares